Mary Jeanne Kreek, Methadone Developer, Dies at 84
Mary Jeanne Kreek, Methadone Developer, Dies at 84
A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.
Mary Jeanne Kreek, Methadone Developer, Dies at 84
Mary Jeanne Kreek, Methadone Developer, Dies at 84

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

translational research
The MSC: Regeneration Orchestrator
The MSC: Regeneration Orchestrator
| Nov 16, 2020
Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.
Thwarting a Pandemic: COVID-19 Vaccine Strategies
Thwarting a Pandemic: COVID-19 Vaccine Strategies
The Scientist Creative Services Team | Aug 6, 2020
Download this poster to learn about promising vaccine candidates for COVID-19!
Biobanking and the Future of Precision Medicine
Biobanking and the Future of Precision Medicine
The Scientist Creative Services Team | Aug 4, 2020
Erik Steinfelder and Bogi Eliasen will examine the importance of biobanking in precision medicine, from early-stage research to diagnostics and treatments.
An Alternative Route to Anesthesia-Induced Anaphylaxis
An Alternative Route to Anesthesia-Induced Anaphylaxis
Ruth Williams | Jul 10, 2019
A study in patients identifies a nontraditional immune pathway that can cause a severe reaction to anesthetic drugs.
Chemogenetics Method Uses Anti-Smoking Drug to Control Cells
Chemogenetics Method Uses Anti-Smoking Drug to Control Cells
Ruth Williams | Mar 14, 2019
A new set of engineered receptors responds to an FDA-approved drug to provide the most potent chemogenetic toolkit to date.
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Will the Noninvasive Glucose Monitoring Revolution Ever Arrive?
Catherine Offord | Oct 12, 2017
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
California Institutes to Merge
California Institutes to Merge
Jef Akst | Oct 25, 2016
The Scripps Research Institute will join forces with the California Institute for Biomedical Research.